Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
MAIA Biotechnology, Inc. (MAIA) had Normalized Income after Taxes of $-22.40M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-22.40M |
|
-- |
|
-- |
|
$24.27M |
|
$-24.27M |
|
$1.87M |
|
$-22.40M |
|
$-22.40M |
|
$-22.40M |
|
$-22.40M |
|
$-22.40M |
|
|
Normalized Income after Taxes |
$-22.40M |
$-24.27M |
|
$-24.27M |
|
32.12M |
|
32.12M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$9.70M |
|
-- |
|
$0.00M |
|
$9.70M |
|
$5.84M |
|
-- |
|
$1.49M |
|
$7.33M |
|
$2.38M |
|
$2.38M |
|
$2.38M |
|
38.62M |
|
| Cash Flow Statement Financials | |
$-18.84M |
|
-- |
|
$17.91M |
|
$9.60M |
|
$8.66M |
|
$-0.94M |
|
$2.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-942.66% |
|
-942.65% |
|
-230.78% |
|
-942.65% |
|
$0.06 |
|
$-0.59 |
|
$-0.59 |
|